Ifosfamide
NDC Package 0703-4100-68

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ifosfamide is used to treat various cancers (such as testicular cancer). Marketed by Teva Parenteral Medicines, Inc, this product is identified by NDC 0703-4100 and is authorized under FDA application ANDA075874.

Identification & Billing

NDC Package Code
0703-4100-68
Package Description
2 VIAL in 1 KIT / 60 mL in 1 VIAL
Product Code
0703-4100
11-Digit Billing Format
00703410068
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Ifosfamide
Dosage Form
-
Usage Information
Ifosfamide is used to treat various cancers (such as testicular cancer). It works by slowing or stopping the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Teva Parenteral Medicines, Inc
FDA Application #
ANDA075874
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-26-2002
End Marketing Date
02-25-2010
Listing Expiration
02-25-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0703-4100). Click a package code to view its specific billing and regulatory data.

0703-4100-48
5 VIAL in 1 KIT / 20 mL in 1 VIAL
0703-4100-48
1 KIT in 1 CARTON * 20 mL in 1 VIAL, SINGLE-DOSE * 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE
0703-4100-58
10 VIAL in 1 KIT / 20 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0703-4100-68 identifies a specific commercial package of 2 vial in 1 kit / 60 ml in 1 vial of Ifosfamide, labeled by Teva Parenteral Medicines, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Parenteral Medicines, Inc on February 26, 2002. The current certification is valid through February 25, 2010.

What are the primary indications for this medication?

Ifosfamide is used to treat various cancers (such as testicular cancer). It works by slowing or stopping the growth of cancer cells.

How is this Teva Parenteral Medicines, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00703410068. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0703-4100-68
11-Digit CMS (5-4-2)
00703-4100-68

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.